Digital tech crucial to success of cancer cell therapy – Novartis
Pairing AI capabilities with human strengths can bring a competitive edge in this rapidly-changing world.
The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?
South Korea is to build a comprehensive database of genetic and biometric data from 10 million people, in a bid to boost its pharma and biotech industry.
Cutting-edge technologies are increasingly improving pharma’s R&D processes.